Figure S3
Effects of dnEGFR expression on ErbB receptor activation and molecular hallmarks in reactive astrocytes. (a) Astrogliosis was induced by stab wound injury in the cortices of both Mlc1-dnEGFR and littermate control mice. Shown are representative GFAP-immunostaining results of injured cortices 3 days or 7 days post injury (dpi). Note the similar increase in GFAP immunoreactivity in the area adjacent to the injury sites in both groups. (b) Nestin expressed in reactive cortical astrocyte 3 days post injury. Cortical slices from Mlc1-dnEGFR and littermate control mice with or without injury were immunostained for GFAP and nestin. Note there were neither GFAP nor nestin expressing in intact cortices. (c) Representative real-time RT-PCR results of EGFR/dnEGFR transcripts in injured cortical tissues of Mlc1-dnEGFR and littermate control mice 3 days post injury. Gel image showed the PCR products of four repeats after full run (40 cycles) of real-time RT-PCR. Note the apparent increase of EGFR/dnEGFR PCR products in Mlc1-dnEGFR group. (d) Quantitative analysis of the transcript increase of dnEGFR in the injured cortical tissues of a Mlc1-dnEGFR mouse in comparison with that of littermate control 3 days post injury. **, P = 0.0012, n = 3 replicates, unpaired t test. (e) Activities of ErbB receptors in primary astrocytes of Mlc1-dnEGFR and control mice induced by ErbB receptor ligands. Primary astrocytes were treated with saline (Ctrl), rhEGF (1 µg/ml), or rhNRG1 (100 ng/ml) for 15 min, respectively, and ErbB receptors and their phosphorylation levels in cell lysates were examined by Western blotting using specific antibodies. (f) Quantitative analyses of ErbB phosphorylation levels revealed by Western blotting in astrocytes stimulated by ErbB ligands. Phosphorylation levels of indicated proteins were normalized by its total protein levels. ##, P < 0.01; #, P < 0.05; as compared with the treatment with saline. ***, P < 0.001; **, P < 0.01; *, P < 0.05; as compared with control astrocytes with the same treatment. n = 3 for each protein, paired t test. Figure S4 AAV-TRE-YFP targeted normal astrocytes in the uninjured cortices and reactive astrocytes in the injured cortices. AAV-TRE-YFP labeled cells were immunopositive for astrocyte marker glutamine synthetase (GS) in either the injured or the uninjured cortices (a), but only positive for nestin in the injured cortices (b), of Mlc1-dnEGFR and Mlc1-tTA mice. Images were taken under the 40X oil-immersion objective of a Zeiss710 confocal microscope. Note the reactive astrocytes labeled by YFP in the injured cortices of both mice on 3 days post injury (dpi) exhibited bigger sizes than those in the uninjured cortices. Moreover, the reactive astrocytes labeled by YFP in the injured cortices of Mlc1-dnEGFR mice were smaller than those in control mice.
Figure S5 Morphological exhibition of cortical astrocytes by TRE-YFP expression. (a)
Comparison of the labeling of cortical reactive astrocytes by TRE-YFP expression and fluorescence dye filling. AAV-TRE-YFP labeled astrocytes in injured cortices 3 days post injury were identified under a fluorescence microscope and filled with fluorescence dye Alexa Fluor 568 by glass micropipettes. Shown are projected images of a labeled astrocyte that were captured at Z-stack series by a Zesiss710 confocal microscope with a 40X oil-immersion objective. Note that YFP labeled cell bodies and all fine processes and exhibited a more complete morphology of the cell than the fluorescence dye did. (b) Shown is the gallery of Z-stack serial images of the same astrocyte in a. Note at every optical slice, YFP exhibited better coverage of the cell than Alexa Fluor 568 did due to labeling of a live cell. Moreover, it was noticeable that the biggest fluorescence area of the astrocyte taken by the confocal microscope was within 6.3-µm Z-axial range through its cell body (from 18.09 µm to 24.12 µm). Primarily cultured astrocytes from Mlc1-ErbB2 V664E brain exhibited different morphology from that of control mice. Shown are representative images of cultured astrocytes in bright field, or immunostained for GFAP, Acsbg1, or RC2. Note normal astrocytes cultured in vitro were flat and adhered well to the dish bottom, while astrocytes isolated from Mlc1-ErbB2 V664E brain were plump and small. (b) Cell growth rate of cultured astrocytes from Mlc1-ErbB2 V664E mice was much faster than that from control mice. Primary cultured astrocytes were plated into 24-well plate at 5×10 3 cells per well, and cells in each well were trypsinized and counted at different time points. **, P < 0.01; ***, P < 0.001; n = 3 replicates for each time point, one-way ANOVA. V664E and control mice were subjected to real-time RT-PCR with specific primers to examine the characteristic genes of A1 or A2 subtypes. Results shown were normalized by the mRNA levels of internal control gapdh and the same genes in control mice. n = 3 replicates for each gene. 
Figure S6

Mlc1-ErbB2
V664E or control mice 20 days after Dox withdrawal were immunostained for GFAP and ErbB2. Enteric glia were labeled by GFAP immunostaining. Arrowheads indicate the cells positive for GFAP but not ErbB2. (b) AAV-TRE-YFP did not label cells in gastrointestinal tract of Mlc1-tTA mice. Small intestine of Mlc1-tTA mice were exposed and 2 µl AAV-TRE-YFP was injected into the intestine wall. One day later the injected part was isolated and sectioned for immunostaining of GFAP. Enteric glia in the submucosa of plicae circulares were positive for GFAP (arrowheads). No YFP signal was detected in the virus-injected intestine sections. There were some spots in the sections exhibited higher green autofluorescence due to tissue folding or overlapping at the edge.
Figure S12
No detectable Src and FAK activities in the uninjured cortices by immunostaining. Cortical slices from uninjured brains of Mlc1-dnEGFR and littermate control mice were co-immunostained by mouse antibodies against Aldh1L1 or Acsbg1, both are previously reported markers for cortical astrocytes, and rabbit/goat antibodies against the active forms of FAK or Src, respectively. Although the antibody against Aldh1L1 failed to label cortical astrocytes, the immunostaining results showed there were neither FAK nor Src activities detected in normal astrocytes of either Mlc1-dnEGFR or control mice.
